Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G93

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsDIAMOND BEAMLINE I02
Synchrotron siteDiamond
BeamlineI02
Temperature [K]100
Detector technologyPIXEL
Collection date2014-12-01
DetectorDECTRIS PILATUS 6M-F
Wavelength(s)0.97944
Spacegroup nameP 1 21 1
Unit cell lengths48.812, 70.514, 60.994
Unit cell angles90.00, 110.30, 90.00
Refinement procedure
Resolution43.950 - 1.670
R-factor0.173
Rwork0.171
R-free0.21300
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.110
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]43.9501.680
High resolution limit [Å]1.6701.670
Rmerge0.0301.166
Number of reflections455011134
<I/σ(I)>19.4
Completeness [%]99.799.8
Redundancy3.3
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.1M HEPES/NaOHpH=7.2, 34.0%w/v MPEG 2000, 0.02M Mercaptoethanol, 0.2M (NH4)2SO4

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon